iBio (IBIO)
(Delayed Data from AMEX)
$1.88 USD
0.00 (0.00%)
Updated May 15, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IBIO 1.88 0.00(0.00%)
Will IBIO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IBIO
New Strong Sell Stocks for October 29th
IBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IBIO
iBio Inc. stock remains steady Wednesday, underperforms market
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
IBIO Stock Earnings: iBio Reported Results for Q3 2024
iBio reports Q3 results
iBio Inc. stock rises Tuesday, outperforms market